Ad is loading...
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
JEMKX
Price
$9.47
Change
-$0.06 (-0.63%)
Updated
Nov 15 closing price
Ad is loading...

FNWFX vs JEMKX

Header iconFNWFX vs JEMKX Comparison
Open Charts FNWFX vs JEMKXBanner chart's image
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
JHancock Emerging Markets Equity R2
Price$9.47
Change-$0.06 (-0.63%)
VolumeN/A
CapitalizationN/A
FNWFX vs JEMKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. JEMKX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and JEMKX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. JEMKX (1.44B). FNWFX pays higher dividends than JEMKX: FNWFX (1.56) vs JEMKX (1.38). FNWFX was incepted earlier than JEMKX: FNWFX (8 years) vs JEMKX (9 years). JEMKX is a more actively managed with annual turnover of: 37.00 vs. FNWFX (32.00). JEMKX has a lower initial minimum investment than FNWFX: JEMKX (0) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 11.59 vs. JEMKX (8.80). FNWFX return over 5 years is better than : 17.23 vs. JEMKX (-11.14).
FNWFXJEMKXFNWFX / JEMKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD7.1474.989143%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B1.44B4,238%
Annual Yield % from dividends1.561.38113%
Returns for 1 year11.598.80132%
Returns for 3 years-14.49-33.5543%
Returns for 5 years17.23-11.14-155%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology